Reproduction, Fertility and Development Reproduction, Fertility and Development Society
Vertebrate reproductive science and technology

15-Deoxy-Δ12,14-prostaglandin J2 and peroxisome proliferator-activated receptor γ (PPARγ) levels in term placental tissues from control and diabetic rats: modulatory effects of a PPARγ agonist on nitridergic and lipid placental metabolism

E. Capobianco A , A. Jawerbaum A C , M. C. Romanini B , V. White A , C. Pustovrh A , R. Higa A , N. Martinez A , M. T. Mugnaini B , C. Soñez B and E. Gonzalez A

A Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Serrano 669, (1414) Buenos Aires, Argentina.

B Departamento de Anatomía Animal, Facultad de Agronomía y Veterinaria, Universidad Nacional de Río Cuarto, (5800) Córdoba, Argentina.

C Corresponding author. Email:

Reproduction, Fertility and Development 17(4) 423-433
Submitted: 30 June 2004  Accepted: 18 December 2004   Published: 15 March 2005


15-Deoxy-Δ12,14-prostaglandin J2 (15dPGJ2) is a peroxisome proliferator-activated receptor γ (PPARγ) ligand that regulates lipid homeostasis and has anti-inflammatory properties in many cell types. We postulated that 15dPGJ2 may regulate lipid homeostasis and nitric oxide (NO) levels in term placental tissues and that alterations in these pathways may be involved in diabetes-induced placental derangements. In the present study, we observed that, in term placental tissues from streptozotocin-induced diabetic rats, 15dPGJ2 concentrations were decreased (83%) and immunostaining for nitrotyrosine, indicating peroxynitrite-induced damage, was increased. In the presence of 15dPGJ2, concentrations of nitrates/nitrites (an index of NO production) were diminished (40%) in both control and diabetic rats, an effect that seems to be both dependent on and independent of PPARγ activation. Exogenous 15dPGJ2 did not modify lipid mass, but decreased the incorporation of 14C-acetate into triacylglycerol (35%), cholesteryl ester (55%) and phospholipid (32%) in placenta from control rats, an effect that appears to be dependent on PPARγ activation. In contrast, the addition of 15dPGJ2 did not alter de novo lipid synthesis in diabetic rat placenta, which showed decreased levels of PPARγ. We conclude that 15dPGJ2 modulates placental lipid metabolism and NO production. The concentration and function of 15dPGJ2 and concentrations of PPARγ were altered in placentas from diabetic rats, anomalies probably involved in diabetes-induced placental dysfunction.


Al-Okail M. S.Al-Attas O. S.1994Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients.Endocr. J.41355360Pubmed Abstract

Asami-Miyagishi R.Iseki S.Usui M.Uchida K.Kubo H.Morita I.2004Expression and function of PPARγ in rat placental development.Biochem. Biophys. Res. Commun.315497501

Barak Y.Nelson M. C.Ong E. S.Jones Y. Z.Ruiz-Lozano P.Chien K. R.Koder A.Evans R. M.1999PPARgamma is required for placental, cardiac, and adipose tissue development.Mol. Cell4585595
Pubmed Abstract

Beckman J. S.Koppenol W. H.1996Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly.Am. J. Physiol.271C1424C1437Pubmed Abstract

Bradford M. M.1976A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding.Anal. Biochem.72248254

Capobianco E.Jawerbaum A.White V.Pustovrh C.Sinner D.Gonzalez E.2003Elevated levels of endothelin-1 and prostaglandin E2 and their effect over nitric oxide generation in placental tissue from neonatal streptozotocin induced diabetic rats.Prostaglandins Leukot. Essent. Fatty Acids68225231
doi:10.1016/S0952-3278(02)00274-0Pubmed Abstract

Capparuccia L.Marzioni D.Giordano A.Fazioli F.De Nictolis M.Busso N.Todros T.Castelluci M.2002PPARγ expression in normal human placenta, hydatidiform mole and choriocarcinoma.Mol. Hum. Reprod.8574579doi:10.1093/MOLEHR/8.6.574Pubmed Abstract

Catalano P.Nizielski S.Shao J.Preston L.Qiao L.Friedman J.2002Downregulated IRS-1 and PPARγ in obese women with gestational diabetes: relationship to FFA during pregnancy.Am. J. Physiol. Endocrinol. Metab.282E522E533Pubmed Abstract

Coughlan M. T.Vervaart V. T.Permezel M.Georgiou H. M.Rice G. E.2004Altered placental oxidative stress status in gestational diabetes mellitus.Placenta257884doi:10.1016/S0143-4004(03)00183-8Pubmed Abstract

Desoye G.Shafrir E.1994Placental metabolism and its regulation in health and diabetes.Mol. Aspects Med.15505682doi:10.1016/0098-2997(94)90004-3Pubmed Abstract

Desoye G.Shafrir E.1996The human placenta in diabetic pregnancy.Diabetes Rev.47089

Diamant Y. Z.Shafrir E.1972Enzymes of carbohydrate and lipid metabolism in the placenta and liver of pregnant rats.Biochim. Biophys. Acta279424430
Pubmed Abstract

Diamant Y. Z.Metzger B. E.Freinkel N.Shafrir E.1982Placental lipid and glycogen content in human and experimental diabetes mellitus.Am. J. Obstet. Gynecol.144511Pubmed Abstract

Forman B. M.Tontoz P.Chen J.Brum R. P.Spiegelman B. M.Evans R. M.199515-Deoxy-delta 12,14 PGJ2 is a ligand for the adipocyte determination factor PPARgamma.Cell83803812doi:10.1016/0092-8674(95)90193-0Pubmed Abstract

Gonzalez E.Jawerbaum A.Novaro V.Sinner D.Gimeno M.1998Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat.Prostaglandins Leukot. Essent. Fatty Acids59299304doi:10.1016/S0952-3278(98)90077-1Pubmed Abstract

Gonzalez E.Jawerbaum A.Sinner D.Pustovrh C.White V.Capobianco E.Xaus C.Peralta C.Roselló-Catafau J.2002Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta 12,14 prostaglandin J2 on nitridergic and prostanoid pathway.Nitric Oxide6214220doi:10.1006/NIOX.2001.0405Pubmed Abstract

Green L. C.Wagner D. A.Glogowski J.1982Analysis of nitrate, nitrite and 15N-nitrate in biological fluids.Anal. Biochem.126131138doi:10.1016/0003-2697(82)90118-XPubmed Abstract

Haggarty P.2002Placental regulation of fatty acid delivery and its effect on fetal growth: a review.Placenta23S28S38doi:10.1053/PLAC.2002.0791Pubmed Abstract

Herrera E.2002Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development: a review.Placenta23S9S19doi:10.1053/PLAC.2002.0771Pubmed Abstract

Holemans K.Aerts L.Van Assche F. A.2003Lifetime consequences of abnormal fetal pancreatic development.J. Physiol.5471120Pubmed Abstract

Ischiropoulos H.1998Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species.Arch. Biochem. Biophys.356111doi:10.1006/ABBI.1998.0755Pubmed Abstract

Jawerbaum A.Gonzalez E. T.Novaro V.Faletti A.Sinner D.Gimeno M. A. F.1998aIncreased prostaglandin E generation and enhanced nitric oxide synthase activity in the non-insulin-dependent diabetic embryo during organogenesis.Reprod. Fertil. Dev.10191196doi:10.1071/R97077Pubmed Abstract

Jawerbaum A.Novaro V.Franchi A. M.Gimeno M.Gonzalez E.1998bHigh glucose levels modulate eicosanoid production in uterine and placental tissue from non-insulin-dependent diabetic rats during late pregnancy.Prostaglandins Leukot. Essent. Fatty Acids58389393doi:10.1016/S0952-3278(98)90158-2

Jawerbaum A.Sinner D.White V.Pustovrh C.Capobianco E.Gonzalez E.2002Modulation of nitric oxide concentration and lipid metabolism by 15deoxy Δ12,14 prostaglandin J2 in embryos from control and diabetic rats during early organogenesis.Reproduction124625631doi:10.1530/REP.0.1240625Pubmed Abstract

Jawerbaum A.Capobianco E.Pustovrh C.White V.Baier M.Salzberg S.Pesaresi M.Gonzalez E.2004Influence of peroxisome proliferators-activated receptor gamma activation by its endogenous ligand 15-deoxy delta 12,14 prostaglandin J2 on nitric oxide production in term placental tissues from diabetic women.Mol. Hum. Reprod.10671676doi:10.1093/MOLEHR/GAH090Pubmed Abstract

Kitzmiller J. L.Cloherty J. P.Younger M. D.Tabatabaii A.Rothchild S. B.Sosenko I.Epstein M. F.Singh S.Neff R. K.1978Diabetic pregnancy and perinatal morbidity.Am. J. Obstet. Gynecol.131560580Pubmed Abstract

Kliewer S. A.Wilson T. M.1998The nuclear receptor PPARgamma: bigger than fat.Curr. Opin. Genet. Dev.8576581doi:10.1016/S0959-437X(98)80014-2Pubmed Abstract

Kliewer S. A.Lenhard J. M.Willson T. M.Patel I.Morris D. C.Lehmann J. M.1995A prostaglandin J2 metabolite binds peroxisome proliferator-activated gamma and promotes adipocyte differentiation.Cell83813819doi:10.1016/0092-8674(95)90194-9Pubmed Abstract

Kossenjans W.Eis A.Sahay R.Brockman D.Myatt L.2000Role of peroxynitrite in altered fetal–placental vascular reactivity in diabetes or preeclampsia.Am. J. Physiol. Heart Circ. Physiol.278H1311H1319Pubmed Abstract

Lehmann J. M.Moore L. B.Smith-Oliver T. A.Wilkison W. O.Wilson T. M.Kliewer S. A.1995An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma.J. Biol. Chem.27012 95312 956doi:10.1074/JBC.270.22.12953

Lyall F.Gibson J. L.Greer I. A.Brockman D. E.Eis A. L. W.Myatt L.1998Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress.Diabetes Care2117531758Pubmed Abstract

Maggi L. B.Sadeghi H.Weigand C.Scarim A. L.Heitmeir M. R.Corbett J. A.2000Anti-inflammatory actions of 15-deoxy-delta 12,14 prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.Diabetes49346355Pubmed Abstract

Maloff B. L.Boyd B. K.1986Physiologic and cellular insulin action in a glucose-intolerant model of type 2 (non-insulin-dependent) diabetes in rats.Diabetologia29295300doi:10.1007/BF00452066Pubmed Abstract

Mimura K.Umeda F.Hiramatsu S.Taniguchi S.Ono Y.Nakashima N.Kobayashi K.Masakado M.Sako Y.Nawata H.1994Effects of a new oral hypoglycaemic agent (CS-0.45) on metabolic abnormalities and insulin resistance in type 2 diabetes.Diabet. Med.11685691Pubmed Abstract

Oakes N. D.Thalen P. G.Jacinto S. M.Ljung B.2001Thiazolidinediones increase plasma–adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.Diabetes5011581165Pubmed Abstract

Portha B.Picon L.Rosselin G.1979Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes.Diabetologia17371377Pubmed Abstract

Pustovrh C.Jawerbaum A.Sinner D.Pesaresi M.Baier M.Gimeno M.Gonzalez E.2000Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pregestational and gestational diabetes mellitusReprod. Fertil. Dev.12269275Pubmed Abstract

Ricote M.Li A. C.Willson T. M.Kelly C. J.Glass C. K.1998The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.Nature3917982doi:10.1038/34178Pubmed Abstract

Rossi A.Kapahi P.Natoli G.Takahashi T.Chen Y.Karin M.Santoro M. G.2000Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase.Nature403103108doi:10.1038/47520Pubmed Abstract

Schaiff W. T.Carlson M.Smith S.Levy R.Nelson D. M.Sadovsky Y.2000Peroxisome proliferator-activated receptor-gamma modulates differentiation of human trophoblast in a ligand-specific manner.J. Clin. Endocrinol. Metab.8538743881doi:10.1210/JC.85.10.3874Pubmed Abstract

Shafrir E.Barash V.1987Placental function in maternal–fetal fat transport in diabetes.Biol. Neonate51101112

Shimabukuro M.Koyama K.Lee Y.Unger R. H.1997Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1β cytotoxicity.J. Clin. Invest.717501754

Straus D. S.Glass C. K.2001Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.Med. Res. Rev.21185210
Pubmed Abstract

Tarrade A.Schoojans K.Guibourdenche J.Bidart J. M.Vidaud M.Auwerx J.Rochette-Egly C.Evain-Brion D.2001aPPARγ/RXRα heterodimers are involved in human CG beta synthesis and human trophoblast invasion.Endocrinology14245044514doi:10.1210/EN.142.10.4504Pubmed Abstract

Tarrade A.Schoojans K.Pavan L.Auwerx J.Rochette-Egly C.Evain-Brion D.Fournier T.2001bPPARγ/RXRα heterodimers control human trophoblast invasion.J. Clin. Endocrinol. Metab.8650175024doi:10.1210/JC.86.10.5017Pubmed Abstract

Wahli W.Braissant O.Desvergne B.1995Peroxisome proliferator-activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more.Chem. Biol.2261266doi:10.1016/1074-5521(95)90045-4Pubmed Abstract

Waite L.Person E.Zhou Y.Kee-Hak L.Scanlan T.Taylor R.2000Placental peroxisome proliferators-activated receptor-gamma is up-regulated by pregnancy serum.J. Clin. Endocrinol. Metab.8538083814doi:10.1210/JC.85.10.3808Pubmed Abstract

Wang Q.Fuhii H.Knipp G. T.2002Expression of PPAR and RXR isoforms in the developing rat and human term placentas.Placenta23661671doi:10.1053/PLAC.2002.0855Pubmed Abstract

White V.Jawerbaum A.Sinner D.Pustovrh C.Capobianco E.Gonzalez E.2002Oxidative stress and altered prostanoid production in the placenta of non-insulin-dependent diabetic rats.Reprod. Fertil. Dev.14117123doi:10.1071/RD01032Pubmed Abstract

White V.Gonzalez E.Capobianco E.Pustovrh C.Soñez C.Romanini M. C.Jawerbaum A.2004Modulatory effect of leptin on nitric oxide production and lipid metabolism in term placental tissues from control and diabetic rats.Reprod. Fertil. Dev.16363372doi:10.1071/RD03095Pubmed Abstract

Export Citation